Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
NCT07134504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2025-08-21
Summary
A 66-year-old male known case of diabetes and hypertension presented to the urology clinic with a 2-month history of lower urinary tract symptoms (LUTS), particularly poor flow, sense of incomplete bladder emptying, dysuria and hesitancy. Family history was negative for prostate or breast cancer.
On examination, there were signs of anaemia or lymphadenopathy. His abdominal examination was unremarkable with no hepatosplenomegaly, and his digital rectal examination (DRE) revealed an irregular, moderately enlarged nodular prostate.
Conditions
Sponsors & Collaborators
-
Instituto Mexicano del Seguro Social
lead OTHER_GOV
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-20
- Primary Completion
- 2025-07-30
- Completion
- 2025-08-01
Countries
- Mexico
Study Locations
More Related Trials
-
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
NCT02454543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma
NCT04909957 ·Status: UNKNOWN
-
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
NCT03503643 ·Status: COMPLETED
-
High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule
NCT01605097 ·Status: COMPLETED ·Phase: NA
-
DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study
NCT01417676 ·Status: COMPLETED ·Phase: NA
-
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer
NCT02766543 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hemi-Ablative Prostate Brachytherapy
NCT02632669 ·Status: COMPLETED ·Phase: NA
-
Early Detection of Prostate Cancer
NCT04556916 ·Status: RECRUITING ·Phase: NA
-
Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy
NCT01909388 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer
NCT05246774 ·Status: UNKNOWN
-
Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis
NCT02998619 ·Status: COMPLETED
-
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
NCT04541030 ·Status: ACTIVE_NOT_RECRUITING
-
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
NCT01826617 ·Status: COMPLETED
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer
NCT01354951 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NCT07184957 ·Status: RECRUITING
-
Protein Kinase A in Prostate Cancer Tissue.
NCT05460312 ·Status: UNKNOWN
-
Evaluation of Prostate Cancer Margins
NCT05317143 ·Status: COMPLETED
-
Early and Accurate Detection of Prostate Cancer in General Practice
NCT03431753 ·Status: UNKNOWN ·Phase: NA
-
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
NCT07131956 ·Status: RECRUITING
-
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer
NCT02237612 ·Status: COMPLETED ·Phase: NA
-
Study of Focal Cryoablation in Low-Risk Prostate Cancer
NCT00774436 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy
NCT04269512 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MRI in Active Surveillance of Prostate Cancer
NCT02326246 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
NCT04909294 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA